Insmed (INSM) Capital Leases (2010 - 2026)

Insmed's Capital Leases history runs 12 years deep, the most recent figure standing at $19.8 million for Q1 2026.

• In Q1 2026, Capital Leases fell 14.81% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $19.8 million (down 14.81% YoY), while the FY2025 annual figure was $20.7 million, down 13.9% from the prior year.
• Capital Leases was $19.8 million for Q1 2026 at Insmed, down from $20.7 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $29.6 million in Q4 2022 to a low of $19.8 million in Q1 2026.
• Historically, Capital Leases has averaged $24.7 million across 5 years, with a median of $24.1 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Capital Leases soared 110.14% in 2022, then dropped 14.81% in 2026.
• A 5-year view of Capital Leases shows it stood at $29.6 million in 2022, then dropped by 8.81% to $27.0 million in 2023, then retreated by 10.96% to $24.1 million in 2024, then dropped by 13.9% to $20.7 million in 2025, then fell by 4.34% to $19.8 million in 2026.
• The last three Capital Leases figures came in at $19.8 million (Q1 2026), $20.7 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.